The new process developed by Rice University researchers makes solar cells that are about 10 times more durable than traditional methods. Photos by Jeff Fitlow/Rice University

A groundbreaking Rice University lab has made further strides in its work to make harvesting light energy more efficient and stable.

Presented on the cover of a June issue of Science, a study from Rice engineer Aditya Mohite's lab uncovered a method to synthesize a high-efficiency perovskite solar cell, known as formamidinium lead iodide (FAPbI3), converting them into ultrastable high-quality photovoltaic films, according to a statement from Rice. Photovoltaic films convert sunlight into electricity.

The new process makes solar cells that are about 10 times more durable than traditional methods.

“Right now, we think that this is state of the art in terms of stability,” Mohite said in a statement. “Perovskite solar cells have the potential to revolutionize energy production, but achieving long-duration stability has been a significant challenge.”

The change come from "seasoning" the FAPbI3 with 2D halide perovskites crystals, which the Mohite lab also developed a breakthrough synthesis process for last year

The 2D perovskites helped make the FAPbI3 films more stable. The study showed that films with 2D perovskites deteriorated after two days of generating electricity, while those with 2D perovskites had not started to degrade after 20 days.

“FAPbI3 films templated with 2D crystals were higher quality, showing less internal disorder and exhibiting a stronger response to illumination, which translated as higher efficiency," Isaac Metcalf, a Rice materials science and nanoengineering graduate student and a lead author on the study, said in the statement.

Additionally, researchers say their findings could make developing light-harvesting technologies cheaper, and can also allow light-harvesting panels to be lighter weight and more flexible.

"Perovskites are soluble in solution, so you can take an ink of a perovskite precursor and spread it across a piece of glass, then heat it up and you have the absorber layer for a solar cell,” Metcalf said. “Since you don’t need very high temperatures ⎯ perovskite films can be processed at temperatures below 150 Celsius (302 Fahrenheit) ⎯ in theory that also means perovskite solar panels can be made on plastic or even flexible substrates, which could further reduce costs.”

Mohite adds this has major implications for the energy transition at large.

“If solar electricity doesn’t happen, none of the other processes that rely on green electrons from the grid, such as thermochemical or electrochemical processes for chemical manufacturing, will happen,” Mohite said. “Photovoltaics are absolutely critical.”

The Mohite lab's process for creating 2D perovskites of the ideal thickness and purity was published in Nature Synthesis last fall. At the time, Mohite said the crystals "hold the key to achieving commercially relevant stability for solar cells."

About a year ago, the lab also published its work on developing a scalable photoelectrochemical cell. The research broke records for its solar-to-hydrogen conversion efficiency rate.

———

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”